Guide for Authors

  • All journal information and instructions compiled in one document (PDF) in just one mouse-click Author information pack

    INTRODUCTION
    • Article categories
    • Contact details for submission
    BEFORE YOU BEGIN
    • Ethics in publishing
    • Ethical approval of studies and Informed consent
    • Conflict of interest
    • Submission declaration and verification
    • Authorship
    • Changes to Authorship
    • Reporting clinical trials
    • Copyright
    • Author rights
    • Funding/support statement
    • Language (usage and editing services)
    • Identification of patients in descriptions, photographs and pedigrees
    • Submission
    PREPARATION
    • General
    • Length of articles
    • Essential title page information
    • Abstract
    • Acknowledgements
    • Units
    • Artwork
    • Tables
    • References
    • Editorial Process
    • Preparation for Publication and Proofs
    • Submission checklist
    AFTER ACCEPTANCE
    • Use of the Digital Object Identifier
    • Online proof correction
    • Offprints
    AUTHOR INQUIRIES



    The Pediatric Infectious Disease Journal, PID, a quarterly publication of the Indian Academy of Pediatrics, Infectious Disease Chapter (IAPIC), is a popular peer reviewed medical journal that publishes articles in the field of pediatric infectious diseases on quarterly basis and is circulated to over 20,000 members of Indian Academy of Pediatricians.

    The journal aims to educate the readers on the entire spectrum of pediatric infectious diseases and provides a useful guide to the practitioners in dealing with infectious diseases in children in their day to day clinical practice.

    The journal publishes Original articles, Review articles, Immunization Update, Notes from lab, Case files, Reading the Shadows, Short Communication and Case Reports etc. The journal also publishes research and latest updates in immunization practices and laboratory methods. The articles like The Big Picture, Review articles and Case Reports make the journal a powerful educative tool. Reading the Shadows is a radiology quiz which encourages the reader to read the radio images correctly and think of possible differential diagnosis when encountered with such images in daily practice. Letters to editor and short communication provide a platform for discussion and expression of the views and personal experiences of readers.

    The Editorial Board requires authors to be in compliance with the Uniform Requirements for Manuscripts Submitted to Biomedical Journals (URMs), which are compiled by the International Committee of Medical Journal Editors (ICMJE); current URMs are available at http://www.icmje.org.

    This Guide for Authors is revised periodically by the Editors as needed. Authors should consult a recent issue of the Journal or visit http://www.elsevier.com/journals/pediatric-infectious-disease/2212-8328/guide-for-authors for the latest version of this guide. Any manuscript not prepared according to this guide will be returned immediately to the author(s) without review.

    Article categories

    The articles are accepted under different sections namely Original Articles, Review Articles, Immunization Update, Notes from the Lab, Case Files, Reading the Shadows (Radiology Quiz), Short Communication, Case Reports, etc. The details of each section are mentioned below:

    Original Articles

    Original articles are scientific reports of the results of original clinical research in the area of pediatric infectious disease. The article should include a structured abstract of fewer than 250 words under the headings: Background, Aim, Methods, Results, Conclusions, and up to 5 keywords for indexing. The length of the article excluding abstract and references should not exceed 2500 words. The author should restrict the number of references to a maximum of 50.

    Review Articles

    Review articles should cover topics relevant to a pediatricians daily practice, emphasizing new developments, and treatments in infectious diseases. The article should include an abstract no longer than 150 words and up to 7 key words for indexing. The length of the article excluding abstract and references should not exceed 2500 words. Special attention should be paid to issues of differential diagnosis, rational investigations, out patient management of the medical problem, decision guidelines for hospitalization and prevention.The author should restrict the number of references to a maximum of 50.

    Case Reports

    A case report should describe a new disease, or confirmation of a rare or new disease; a new insight into pathogenesis,etiology, diagnosis, or treatment; or a new finding associated with a currently known disease. The text should not exceed 1000 words and should be arranged as introduction, case report and discussion. The case report should include a brief abstract of about 100 words, up to 5 keywords and upto 10 references. The case report should not include any tables or graphics. However, authors are encouraged to submit relevant pictures and photographs to enhance the academic value of the case being discussed.

    Immunization Update

    This should discuss original study, review article, future vaccine, vaccine alert, adverse drug reactions, and recommendations.The text should not exceed 2000 words with 25 references. The authors should provide up to 5 keywords for indexing.

    Antimicrobials in Clinical Practice

    This section should discuss an antimicrobial of clinical importance. The details should include spectrum, mechanisms of resistance, pharmacokinetics, pharmacodynamics,side effects, contraindications, and clinical uses. The text should not exceed 2500 words with 25 references. The authors should provide up to 5 keywords for indexing.

    Correspondence

    Letters to the editor may be in response to published articles or an expression of the general opinion of the reader. Letters should be about 300 words long, with no more than 5 references

    Contact details for submission

    If assistance is required by the authors, please refer to the tutorials for authors and/or customer support that are available on the EES website; you may also contact the Editorial Office. Please do not post, fax or e-mail your manuscripts to the Editorial Office.

    Editorial Office
    Dr. Vijay Yewale
    Dr. Yewale's Multispeciality Hospital for Children,
    Vashi, Navi Mumbai, India
    Email: vnyewale@gmail.com



    Manuscripts submitted to Indian Journal of Rheumatology should not have been published previously or be under simultaneous consideration for publication by any other journal. Violation may lead to a retraction of the published article by the Journal and other actions as deemed necessary by the editor. All articles (including those invited) will be peer-reviewed, and accepted articles will be edited to the Journal's style. Accepted manuscripts become the permanent property of the Journal and may not be reproduced, in whole or in part, without the written permission of the editor. Studies involving human subjects or animals should have received the approval of the institutional ethics committee. A statement to this effect and that informed consent was obtained from participating human subjects must be included in the manuscript text.

    Ethics in publishing

    For information on Ethics in publishing and Ethical guidelines for journal publication see http://www.elsevier.com/publishingethics and http://www.elsevier.com/journal-authors/ethics.

    Ethical approval of studies and Informed consent

    Studies involving human subjects or animals should have received the approval of the institutional ethics committee. A statement to this effect and that informed consent was obtained from participating human subjects must be included in the manuscript text. Please ensure that the work described has been carried out in accordance with The Code of Ethics of the World Medical Association (Declaration of Helsinki) for experiments involving humans http://www.wma.net/en/30publications/10policies/b3/index.html; EU Directive 2010/63/EU for animal experiments http://ec.europa.eu/environment/chemicals/lab_animals/legislation_en.htm; Uniform Requirements for manuscripts submitted to Biomedical journals http://www.icmje.org. Authors should include a statement in the manuscript that informed consent was obtained for experimentation with human subjects. The privacy rights of human subjects must always be observed.

    Conflict of interest

    All authors must disclose any financial and personal relationships with other people or organizations that could inappropriately influence (bias) their work. Examples of potential conflicts of interest include employment, consultancies, stock ownership, honoraria, paid expert testimony, patent applications/registrations, and grants or other funding. If there are no conflicts of interest then please state this: 'Conflicts of interest: none'. See also http://www.elsevier.com/conflictsofinterest. Further information and an example of a Conflict of Interest form can be found at: http://help.elsevier.com/app/answers/detail/a_id/286/p/7923.

    Submission declaration and verification

    Submission of an article implies that the work described has not been published previously (except in the form of an abstract or as part of a published lecture or academic thesis or as an electronic preprint, see http://www.elsevier.com/sharingpolicy), that it is not under consideration for publication elsewhere, that its publication is approved by all authors and tacitly or explicitly by the responsible authorities where the work was carried out, and that, if accepted, it will not be published elsewhere in the same form, in English or in any other language, including electronically without the written consent of the copyright-holder. To verify originality, your article may be checked by the originality detection service CrossCheck http://www.elsevier.com/editors/plagdetect.

    Authorship

    All authors should have made substantial contributions to all of the following: (1) the conception and design of the study, or acquisition of data, or analysis and interpretation of data, (2) drafting the article or revising it critically for important intellectual content, (3) final approval of the version to be submitted. Please give contribution of each author on the cover page of the manuscript.

    Changes to Authorship

    Ideally there should not be any change in authorship after the manuscript is submitted. In situations where there has been an omission or substantial work is done when the article is revised, an author's name may be added. This policy concerns the addition, deletion, or rearrangement of author names in the authorship of accepted manuscripts:
    Before the accepted manuscript is published in an online issue: Requests to add or remove an author, or to rearrange the author names, must be sent to the Journal Manager from the corresponding author of the accepted manuscript and must include: (a) the reason the name should be added or removed, or the author names rearranged and (b) written confirmation (e-mail, fax, letter) from all authors that they agree with the addition, removal or rearrangement. In the case of addition or removal of authors, this includes confirmation from the author being added or removed. Requests that are not sent by the corresponding author will be forwarded by the Journal Manager to the corresponding author, who must follow the procedure as described above. Note that: (1) Journal Managers will inform the Journal Editors of any such requests and (2) publication of the accepted manuscript in an online issue is suspended until authorship has been agreed upon by the editor.
    After the accepted manuscript is published in an online issue: Any requests to add, delete, or rearrange author names in an article published in an online issue will follow the same policies as noted above and result in a corrigendum.

    Reporting clinical trials

    All randomized controlled trials submitted for publication should include a completed Consolidated Standards of Reporting Trials (CONSORT) flow chart (please go to http://www.consort-statement.org for more information). The IJR has adopted the ICMJE proposal that requires, as a condition of consideration for publication of clinical trials, registration in a public trials registry. Trials must register at or before the onset of patient enrolment. The clinical trial registration number should be included at the end of the abstract of the article.

    For this purpose, a clinical trial is defined as any research study that prospectively assigns human participants or groups of humans to one or more health-related interventions to evaluate the effects of health outcomes. Health-related interventions include any intervention used to modify a biomedical or health-related outcome (for example drugs, surgical procedures, devices, behavioral treatments, dietary interventions, and process-of-care changes). Health outcomes include any biomedical or health-related measures obtained in patients or participants, including pharmacokinetic measures and adverse events.

    Purely observational studies (those in which the assignment of the medical intervention is not at the discretion of the investigator) will not require registration. Further information can be found at http://www.icmje.org.

    Copyright

    Pediatric Infectious Disease (PID, is the official, peer-reviewed publication of the Indian Academy of Pediatrics, Infectious Disease Chapter (IAPIC). Manuscripts published in the PID become the permanent property of the IAPIC. All articles published in the Journal are protected by copyright, which covers the exclusive rights to reproduce and distribute the article, as well as translation rights. No PID article, in part or whole, may be reproduced, stored in any retrieval system, or transmitted in any form or by any means, electronic, mechanical, by photocopying, recording, or otherwise, without prior written permission from the IAPIC.

    Upon acceptance of an article, authors will be asked to complete a 'Journal Publishing Agreement' (for more information on this and copyright see http://www.elsevier.com/copyright). Acceptance of the agreement will ensure the widest possible dissemination of information. An e-mail will be sent to the corresponding author confirming receipt of the manuscript together with a 'Journal Publishing Agreement' form or a link to the online version of this agreement.

    Author rights

    As an author you (or your employer or institution) have certain rights to reuse your work. For more information see http://www.elsevier.com/copyright.

    Funding/support statement

    All financial and material support for the research, work, writing and editorial assistance from internal or external agencies, including commercial companies, should be clearly and completely identified in a Funding/Support Statement. You are requested to identify who provided financial support for the conduct of the research and/or preparation of the article and to briefly describe the role of the sponsor(s), if any, in study design; in the collection, analysis and interpretation of data; in the writing of the report; and in the decision to submit the article for publication. If the funding source(s) had no such involvement then this should be stated. Please see http://www.elsevier.com/funding.

    Language (usage and editing services)

    Articles should be written in English, using American English spelling. Authors who feel their English language manuscript may require editing to eliminate possible grammatical or spelling errors and to conform to correct scientific English may wish to use the English Language Editing service available from Elsevier's WebShop http://webshop.elsevier.com/languageediting/ or visit our customer support site http://support.elsevier.com for more information.

    Identification of patients in descriptions, photographs and pedigrees

    A signed statement of informed consent to publish (in print and online) patient descriptions, photographs and pedigrees should be obtained from all persons (parents or legal guardians for minors) who can be identified (including by the patients themselves) in such written descriptions, photographs or pedigrees. Such persons should be shown the manuscript before its submission. Omitting data or making data less specific to de-identify patients is acceptable, but changing any such data is not acceptable. State explicitly in the methods section of the manuscript that informed consent was obtained from all participating adult subjects or from parents or legal guardians for minors or incapacitated adults, together with the manner in which informed consent was obtained (i.e., oral or written).

    Submission

    Our online submission system guides you stepwise through the process of entering your article details and uploading your files. The system converts your article files to a single PDF file used in the peer-review process. Editable files (e.g., Word, LaTeX) are required to typeset your article for final publication. All correspondence, including notification of the Editor's decision and requests for revision, is sent by e-mail.

    The Journal only accepts online submissions in electronic format. All new manuscripts must be submitted through Indian Journal of Rheumatology online and review website (http://ees.elsevier.com/pid). Please follow the following steps to submit your manuscript:
    1. Open the homepage of the Journal's website http://ees.elsevier.com/pid.
    2. Register yourself for free by clicking on register on the top and create a user profile with a desired username and mandatory details. On submission of the information, you will receive an email confirming your registration along with the 'Password'
    3. Click "Log In" on the main navigation menu at the top of the journal screen to open the login page.
    4. Enter your username and password in the appropriate fields (e-mailed to you at the time of registration).
    5. Click "Author Log in", this takes you to the "Author Main Menu".
    6. After that you can submit the manuscript by following the instructions provided on the screen.
    7. Revised manuscripts can be uploaded online using the same log in.
    If you have any problems in submission of your manuscript, please send us an email at vnyewale@gmail.com.

    Note : Please note that the username and password combination required for Elsevier Editorial System is different from your username and password combination used to "Track your paper" on the Elsevier "Authors' Home" website.

    By submitting a manuscript online, the author agrees to the following:
    1. The work is original and free from plagiarism.
    2. It has neither been published, nor is it not under consideration for publication at another journal.
    3. All authors are aware of the authorship order. The corresponding author shall be responsible in case of dispute.
    4. Once published, copyright of manuscript shall stand transferred to the Journal.
    5. 'Conflict of interest' if any, must be explicitly stated at the end of the manuscript.

    Submit your article
    Please submit your article via http://ees.elsevier.com/pid/.



    Manuscripts must conform to the instructions given below:

    General

    Type the manuscript using 'Times New Roman' font, size 12 in double space throughout. Please arrange the manuscript as follows: Title page, Abstract, Introduction, Methods, Results, Discussion, and References. Number all pages consecutively, beginning with the title page. All figures and Tables must be referred to in the manuscript. Consult a recent issue of the Journal for details. Only the Title page should bear the names and addresses of the author(s). Editorials, perspective and review articles are generally by invitation. However if you are interested in writing a review/perspective, you can send an email to the editor with the topic and a short summary of contents to be included. The editor will convey her decision in 7-10 days' time.

    Length of articles

    Text of original articles should be between 2000 and 3500 words. The article should not ordinarily contain more than 3 tables, 2 figures and 25 references. Case Reports with an interesting image can be accepted as 'Images in Rheumatology'. This report should be of about 750 words including discussion with 1–2 images and 5–6 references. Letters discussing or criticizing material published recently in the Journal, brief presentations of data, or those pertaining to issues of relevance to health policy, practice of medicine, or the like, are welcome. These should not exceed 500 words, 1 table and 5 references.

    Essential title page information

    Title. Concise and informative. Titles are often used in information-retrieval systems. Avoid abbreviations and formulae where possible.
    Author names and affiliations. Please clearly indicate the given name(s) and family name(s) of each author and check that all names are accurately spelled. Present the authors' affiliation addresses (where the actual work was done) below the names. Indicate all affiliations with a lower-case superscript letter immediately after the author's name and in front of the appropriate address. Provide the full postal address of each affiliation, including the country name and, if available, the e-mail address of each author.
    Corresponding author. Clearly indicate who will handle correspondence at all stages of refereeing and publication, also post-publication. Ensure that the e-mail address is given and that contact details are kept up to date by the corresponding author.
    Present/permanent address. If an author has moved since the work described in the article was done, or was visiting at the time, a 'Present address' (or 'Permanent address') may be indicated as a footnote to that author's name. The address at which the author actually did the work must be retained as the main, affiliation address. Superscript Arabic numerals are used for such footnotes.

    In animal studies, the title should state the species; all other titles will refer to human studies. State names of authors (including first names), the departments and the institution where the work was done. Please do not add your academic qualifications, designation etc. State contribution of each author clearly. A short, running title, not exceeding 40 characters, should be provided. Please provide the name, postal address with PIN code, facsimile number and E-mail address of the author to whom communications and proofs are to be sent. Acknowledgements, if any, may be mentioned on this page.

    Abstract

    Original articles should include a structured abstract of upto 250 words under the following headings: Introduction, Methods, Results, and Conclusions. [See Ann Intern Med 1990; 113: 69–76]. References should not be included. Upto10 key words, not present in the title, to assist indexing, should be provided below the Abstract in alphabetical order; these may be obtained from the Medical Subject Headings (MeSH) database of National Library of Medicine, USA.

    Acknowledgements

    These should appear at the end of the manuscript. The source of funding as well as a disclosure statement mentioning conflict of interest, if any, should appear under this heading.

    Units

    All measurements must be in metric units, preferably with corresponding SI units in parentheses.

    Artwork

    Electronic artwork
    General points
    • Make sure you use uniform lettering and sizing of your original artwork.
    • Embed the used fonts if the application provides that option.
    • Aim to use the following fonts in your illustrations: Arial, Courier, Times New Roman, Symbol, or use fonts that look similar.
    • Number the illustrations according to their sequence in the text.
    • Use a logical naming convention for your artwork files.
    • Provide captions to illustrations separately.
    • Size the illustrations close to the desired dimensions of the published version.
    • Submit each illustration as a separate file.
    A detailed guide on electronic artwork is available on our website:
    http://www.elsevier.com/artworkinstructions.
    You are urged to visit this site; some excerpts from the detailed information are given here.
    Formats
    If your electronic artwork is created in a Microsoft Office application (Word, PowerPoint, Excel) then please supply 'as is' in the native document format.
    Regardless of the application used other than Microsoft Office, when your electronic artwork is finalized, please 'Save as' or convert the images to one of the following formats (note the resolution requirements for line drawings, halftones, and line/halftone combinations given below):
    EPS (or PDF): Vector drawings, embed all used fonts.
    TIFF (or JPEG): Color or grayscale photographs (halftones), keep to a minimum of 300 dpi.
    TIFF (or JPEG): Bitmapped (pure black & white pixels) line drawings, keep to a minimum of 1000 dpi.
    TIFF (or JPEG): Combinations bitmapped line/half-tone (color or grayscale), keep to a minimum of 500 dpi.
    Please do not:
    • Supply files that are optimized for screen use (e.g., GIF, BMP, PICT, WPG); these typically have a low number of pixels and limited set of colors;
    • Supply files that are too low in resolution;
    • Submit graphics that are disproportionately large for the content.

    Figures/Illustrations/Photographs
    Photographs of 300 dpi or higher resolution may be submitted as 'jpeg', or 'tiff ' files in a zipped folder. In clinical photographs, identity of the subjects should be suitably masked; in case this is not possible, a written permission from the concerned person should accompany the manuscript.

    Legends to Figures
    The figure number (numbered consecutively in Arabic numerals), title and explanations of the figures should appear in the legend (not on the figure). Type the legends on a separate page. Enough information should be included to interpret the figure without reference to the text.

    Tables

    Each table should be typed on a separate page and numbered consecutively in Arabic numerals. Each table should have a title and all abbreviations should be explained in the footnote. Necessary explanatory notes, if any, may be given below the table.

    Citation in text
    Please ensure that every reference cited in the text is also present in the reference list (and vice versa). Any references cited in the abstract must be given in full. Unpublished results and personal communications are not recommended in the reference list, but may be mentioned in the text. If these references are included in the reference list they should follow the standard reference style of the journal and should include a substitution of the publication date with either 'Unpublished results' or 'Personal communication'. Citation of a reference as 'in press' implies that the item has been accepted for publication.

    References

    Number the references in the order in which they first appear in the text and identify the reference numbers in the text in superscript. References must be placed at the end of the manuscript. Please use recent references as much as possible. The responsibility for accuracy of references lies with the respective authors. The Journal is in agreement with the International Committee of Medical Journal Editors (http://www.icmje.org). The general arrangement, abbreviations of Journal names and punctuations followed are as per the Uniform Requirements for Manuscripts submitted to Biomedical Journals (http://www.icmje.org). Please pay attention to the style of references and punctuations as follows:

    Journal article
    List all authors when six or less as shown in the example below:

    Tallon D, Chard J, Dieppe P. Exploring the priorities of patients with osteoarthritis of the knee. Arthritis Care and Res 2000; 13: 312–9.

    When there are seven or more authors, list only the first six and add et al.

    Book or monograph
    Following is an example: Cassidy JT. Juvenile rheumatoid arthritis. In: Textbook of Rheumatology 6th ed, Kelly et al (eds) Philadelphia Saunders 2000; pp. 1297–313.

    Editorial Process

    All articles submitted to the Journal undergo initial review by the Editor/associate editor and articles that are outside the scope of Journal or are not in the journal format are excluded. Later each article is reviewed by at least two reviewers. The time to first decision is usually less than 6 weeks.

    As per the policy of the Journal, an Editor, who is either author of a manuscript or belongs to the same institution as any of the authors, is not assigned that manuscript and is not involved in decision-making regarding its publication. Reviewers/Editorial Board members should decline the invitation to review a manuscript which is submitted by authors from their institution.

    Preparation for Publication and Proofs

    Once a manuscript has been accepted for publication, authors should submit the final version of their manuscript in MS Word format, with all tables/figures as applicable, via the EES. Accepted manuscripts are then copyedited according to the Journal's style and the galley proofs in the form of a PDF file are sent by the Publisher to the corresponding author for final approval. Authors are responsible for all statements made in their work, including changes made by the copy editor.

    Proofreading is solely the authors' responsibility. Note that the Editorial Board reserves the right to make revisions to the manuscript and the Publisher may proceed with the publication of your article if no response from the author(s) is received.

    Submission checklist

    The following list will be useful during the final checking of an article prior to sending it to the journal for review. Please consult this Guide for Authors for further details of any item.
    Ensure that the following items are present:
    One author has been designated as the corresponding author with contact details:
    • E-mail address
    • Full postal address
    All necessary files have been uploaded, and contain:
    • Keywords
    • All figure captions
    • All tables (including title, description, footnotes)
    Further considerations
    • Manuscript has been 'spell-checked' and 'grammar-checked'
    • References are in the correct format for this journal
    • All references mentioned in the Reference list are cited in the text, and vice versa
    • Permission has been obtained for use of copyrighted material from other sources (including the Internet)
    Printed version of figures (if applicable) in color or black-and-white
    • Indicate clearly whether or not color or black-and-white in print is required.
    • For reproduction in black-and-white, please supply black-and-white versions of the figures for printing purposes.
    For any further information please visit our customer support site at http://support.elsevier.com.

    Use of the Digital Object Identifier

    The Digital Object Identifier (DOI) may be used to cite and link to electronic documents. The DOI consists of a unique alpha-numeric character string which is assigned to a document by the publisher upon the initial electronic publication. The assigned DOI never changes. Therefore, it is an ideal medium for citing a document, particularly 'Articles in press' because they have not yet received their full bibliographic information. Example of a correctly given DOI (in URL format; here an article in the journal Physics Letters B):
    http://dx.doi.org/10.1016/j.physletb.2010.09.059
    When you use a DOI to create links to documents on the web, the DOIs are guaranteed never to change.

    Online proof correction

    Corresponding authors will receive an e-mail with a link to our online proofing system, allowing annotation and correction of proofs online. The environment is similar to MS Word: in addition to editing text, you can also comment on figures/tables and answer questions from the Copy Editor. Web-based proofing provides a faster and less error-prone process by allowing you to directly type your corrections, eliminating the potential introduction of errors.
    If preferred, you can still choose to annotate and upload your edits on the PDF version. All instructions for proofing will be given in the e-mail we send to authors, including alternative methods to the online version and PDF.
    We will do everything possible to get your article published quickly and accurately. Please use this proof only for checking the typesetting, editing, completeness and correctness of the text, tables and figures. Significant changes to the article as accepted for publication will only be considered at this stage with permission from the Editor. It is important to ensure that all corrections are sent back to us in one communication. Please check carefully before replying, as inclusion of any subsequent corrections cannot be guaranteed. Proofreading is solely your responsibility.

    Offprints

    The corresponding author, at no cost, will be provided with a personalized link providing 50 days free access to the final published version of the article on ScienceDirect. This link can also be used for sharing via email and social networks. For an extra charge, paper offprints can be ordered via the offprint order form which is sent once the article is accepted for publication. Both corresponding and co-authors may order offprints at any time via Elsevier's WebShop (http://webshop.elsevier.com/myarticleservices/offprints). Authors requiring printed copies of multiple articles may use Elsevier WebShop's 'Create Your Own Book' service to collate multiple articles within a single cover (http://webshop.elsevier.com/myarticleservices/offprints/myarticlesservices/booklets).



    You can track your submitted article at http://www.elsevier.com/track-submission. You can track your accepted article at http://www.elsevier.com/trackarticle. You are also welcome to contact Customer Support via http://support.elsevier.com.

Advertisement

advert image